tiprankstipranks
Santen Pharmaceutical Co Ltd (MX:4536N)
:4536N
Mexico Market
4536N
Santen Pharmaceutical Co
RESEARCH TOOLSreports

Santen Pharmaceutical Co (4536N) Income Statement

0 Followers

Santen Pharmaceutical Co Income Statement

Last quarter (Q2 2026), Santen Pharmaceutical Co's total revenue was ¥69.14B, a decrease of -14.49% from the same quarter last year. In Q2, Santen Pharmaceutical Co's net income was ¥8.06B. See Santen Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 300.00B¥ 291.62B¥ 301.96B¥ 279.04B¥ 266.26B
Gross Profit
¥ 163.21B¥ 160.97B¥ 163.88B¥ 156.57B¥ 146.85B
Operating Expenses
¥ 106.98B¥ 115.75B¥ 111.97B¥ 124.55B¥ 110.88B
Depreciation and Amortization
¥ 17.95B¥ 18.36B¥ 18.18B¥ 17.25B¥ 17.05B
EBITDA
¥ 66.51B¥ 67.79B¥ 48.88B¥ 11.94B¥ 52.92B
Operating Income
¥ 56.23B¥ 45.22B¥ 51.90B¥ 32.02B¥ 35.98B
Other Income/Expenses
¥ -8.75B¥ 2.23B¥ -22.03B¥ -37.81B¥ -360.00M
Pretax Income
¥ 47.48B¥ 47.44B¥ 29.87B¥ -5.80B¥ 35.62B
Net Income
¥ 36.26B¥ 37.37B¥ 26.64B¥ -14.95B¥ 27.22B
Per Share Metrics
Basic EPS
¥ 103.98¥ 114.04¥ 72.59¥ -38.60¥ 68.07
Diluted EPS
¥ 103.68¥ 113.80¥ 72.37¥ -38.60¥ 67.97
Weighted Average Shares Outstanding
 348.61M 327.62M 366.89M 387.42M 399.77M
Weighted Average Shares Outstanding (Diluted)
 349.69M 328.37M 368.14M 387.42M 400.46M
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History